Article
Clinical decision support systems vs AI chatbots
Clinical decision support systems and AI chatbots can both inform care, but neither label proves a tool is clinically validated or keeps an adequate audit trail. Check the evidence behind recommendations, patient linkage, clinician review, version records, and export options. Retained chats can be exportable in eligible accounts; an export alone is not a clinical decision record. This guide shows what to verify before relying on either workflow.
In the AMA's 2024 survey of 1,183 physicians, 66% reported using AI in their practice, compared with 38% in 2023. A retained chat or export can show the questions and AI responses. It records your final decision and reasoning only if you document them; the clinical workflow must also connect that record to the correct patient.
State regulators have started testing healthcare AI claims against evidence. In 2024, the Texas Attorney General settled with Pieces Technologies, a Dallas company whose generative AI tool summarized patient records at several Texas hospitals, over allegations that it had overstated the tool's accuracy. The case is covered below.
This article explains how a CDSS differs from an AI chatbot, what each one records, and what that record is worth when a regulator, a carrier, or a plaintiff's attorney asks how a decision was made.
How is a CDSS different from an AI chatbot?
A CDSS is designed to support clinical decisions; a general AI chatbot provides conversational responses. Either workflow needs evidence, practitioner review, and verifiable records.
What is a clinical decision support system?
A clinical decision support system helps healthcare practitioners make clinical decisions. Evaluate the specific product against these five criteria; the CDSS label alone does not establish that it meets them.
Check clinical validation. Ask what evidence supports accuracy, safety, and effectiveness for the intended use and patient population, including independent, peer-reviewed studies where available. Do not assume every product has that evidence.
Check practitioner oversight. Ask the vendor to demonstrate how the workflow presents findings, captures your review, and records whether you approve, modify, or reject a recommendation, with a timestamp.
Check the audit trail. Verify which actions the system logs, including access, inputs, recommendations, and clinician decisions. Request a sample export rather than assuming every interaction is recorded.
Check version tracking. Ask whether each decision record identifies the algorithm or model version used and whether the vendor preserves a history of changes.
Check post-release monitoring. Ask how the vendor measures performance, investigates errors, and communicates model or guideline changes.
What is an AI chatbot?
An AI chatbot, such as ChatGPT, Claude, Gemini, or Perplexity, uses language models to answer questions conversationally. Five things about it matter in clinical practice.
Do not infer clinical validation from general medical-task performance. Researchers have evaluated ChatGPT on tasks such as USMLE questions. That evidence does not by itself establish suitability for the model, patient population, or prescribing workflow you intend to use.
Verify the review step. A conversational answer alone does not establish that clinician review is required or recorded. Check the specific product and any clinical integrations for how decisions and reasoning are captured.
Chat history alone is not a structured clinical audit trail. OpenAI's export guidance explains how eligible accounts can download retained chat history; managed workspaces have different access rules. An export does not, by itself, establish that the conversation is linked to the correct patient or that a clinician reviewed, accepted, changed, or rejected a suggestion. Verify how those actions and the final reasoning are documented in the clinical record.
Verify version records. Model identification, update notices, retention, and export options vary by product and account. Check whether a record identifies the version that produced a specific answer.
It does not carry clinical accountability. OpenAI's usage policies bar using its services for tailored advice that requires a license, such as medical advice, without appropriate involvement by a licensed professional. A chatbot does not replace your responsibility to assess its recommendations and meet applicable professional requirements.
How do they compare side by side?
| Factor | CDSS | AI chatbot |
|---|---|---|
| Clinical validation | Validation data you can request, ideally peer-reviewed | Verify evidence for the specific model and intended population |
| Audit trail | Verify which recommendations and decisions are logged | Retained chat may be exportable; verify patient linkage and decision capture |
| Practitioner review loop | Verify that review is required and documented | Verify whether review is required and recorded |
| Governance framework | Verify the governance functions provided | Verify product functions and the practice's added controls |
| Regulatory alignment | Can be built to let you review the basis for each recommendation, as FDA's CDS guidance describes | Check intended use and the specific clinical workflow |
| Version control | Verify version history and retention | Verify model/version metadata available to the user |
| Ongoing monitoring | Verify the vendor's performance-monitoring process | Verify monitoring relevant to the intended clinical use |
| Documentation | Verify that the record captures clinician review | Verify how review and final decisions are documented |
Compare the actual record each product produces. Neither a CDSS label nor a chat transcript alone proves that the clinical decision and reasoning are documented.
Why do regulators care about audit trails?
Federal regulators and professional bodies have published guidance on clinical AI, and state boards judge your decisions against the standard of care. Both come down to what you can show about how a decision was made.
What does an audit trail record?
An audit trail is a timestamped record of system activity. For clinical use, verify whether it captures:
- Who accessed the system (your user ID)
- What was entered or retrieved (patient data, clinical query)
- When it happened (date and time)
- What recommendation was generated
- What you decided (approved, modified, rejected)
- Why you made that decision (your documented reasoning)
In a regulatory investigation or malpractice litigation, the audit trail shows the process you followed.
Take a hypothetical. A state attorney general's office is looking at your peptide prescribing and asks you to show your process for deciding dosages.
If you used a general chatbot, retained chat history may show what you asked and what it answered. You still need to show where the correct patient, your review, and your final decision were documented, whether in the clinical record or a verified integration.
If you used a CDSS with audit trails, your answer can be a list of each decision, the algorithm version used, and your note on why you approved or changed the recommendation.
The second answer lets the reviewer check your process against a record.
What happened in the Texas AG settlement with a healthcare AI vendor?
In September 2024, the Texas Attorney General announced a settlement with Pieces Technologies, a Dallas company whose generative AI product summarized patients' conditions and treatment for staff at several Texas hospitals.
The AG alleged that Pieces marketed the product as highly accurate, including a claimed severe hallucination rate below 1 in 100,000, and that those claims were likely inaccurate and may have misled hospital customers about the product's accuracy and safety.
Pieces denied wrongdoing in the settlement agreement. Under it, Pieces agreed to accurately disclose the extent of its products' accuracy and to make sure hospital staff understand how far they should rely on the product.
The agreement addresses the vendor's marketing and disclosures, rather than a clinician's prescribing decisions. Its lesson for a practice is narrow: regulators asked what the AI tool could be shown to do, and the answer had to come from evidence.
What do the FDA, AMA, and HIMSS say?
FDA. The FDA's Clinical Decision Support Software guidance, finalized in September 2022 and revised on January 29, 2026, explains which CDS software functions fall outside the definition of a medical device under section 520(o)(1)(E) of the FD&C Act. It sets no rules for clinicians who use CDS. One of its criteria is a useful buying test: to fall outside device regulation, the software must let the health care professional independently review the basis for its recommendations. To support that review, FDA recommends that the software or its labeling provide:
- The intended use, the intended user, and the intended patient population
- The input medical information the software requires, with plain-language instructions
- A plain-language description of how the underlying algorithm was developed and validated
- Relevant patient-specific information and other knowns and unknowns for the professional to consider
The FDA doesn't regulate your use of a general chatbot through this guidance. But a tool that can't show you the basis for a recommendation gives you nothing to review or document.
AMA. The American Medical Association's principles for augmented intelligence development, deployment, and use address oversight, transparency, disclosure and documentation, generative AI, privacy and security, bias, and liability. Two points bear on this article. Key characteristics of an AI tool should be disclosed across its design, development, and deployment. And when AI directly affects patient care or medical decision-making, that use should be disclosed and documented.
HIMSS. The Healthcare Information and Management Systems Society's AI global policy principles cover safety, accountability, transparency, and privacy, and call for AI to be monitored and revalidated after deployment.
What does a practitioner review workflow look like?
A CDSS needs a review workflow: a defined point where a clinician checks each recommendation and the decision is recorded.
What are the steps in the review loop?
- Input. You enter patient data or a clinical question.
- Recommendation. The CDSS generates a recommendation, such as a monitoring interval or a safety parameter.
- Review. You check the recommendation against your clinical judgment, the patient's history, and contraindications.
- Decision. You approve the recommendation, modify it, or reject it.
- Documentation. Record your decision and reasoning in the verified documentation workflow.
- Action. You carry out your decision in the patient record.
- Audit trail. Verify that the record is preserved and can be retrieved for later review.
The loop keeps you engaged with each recommendation, and it documents your judgment so you can show that you reviewed and decided.
Scriptura’s Clinical Council invites clinicians to contribute specialty evidence review and workflow feedback. Council input informs development; treating practitioners retain clinical decisions.
How do you build the workflow in a practice?
Assign responsibility. Name one person or a small team as the CDSS governance lead. They own algorithm updates, audit trail review, and outcome monitoring.
Review outcomes on a schedule appropriate to the system’s risks and your practice. A quarterly review is one possible operational starting point, not a regulatory or clinical standard. Pull the audit logs and ask:
- How many recommendations did you approve, modify, and reject?
- Were there patterns, such as the algorithm consistently recommending doses you had to lower?
- Did patient outcomes line up with the recommendations?
- Were any adverse events tied to a recommendation?
Write these reviews down. They show a regulator or an insurer that someone is watching the system.
Log every override. Each time you override a recommendation, document why. That note is evidence that you considered the recommendation and made an informed decision.
Track decisions. Use the CDSS's own logging, or a spreadsheet if you must, to record the date and time of each decision, a patient identifier, the recommendation given, your decision, and the outcome if known.
Where do general chatbots fall short?
Check whether the particular chat product and its integrations support this workflow. A basic conversation alone does not establish the following controls:
- A recorded review step: where does the clinician accept, modify, or reject the suggestion?
- Patient and outcome linkage: how is the conversation connected to the clinical record and follow-up?
- Retention and exports: which conversations can be retained and exported, and what information about review and decisions do they contain?
- Governance: where is the clinician's reasoning recorded, and how can the practice review decisions over time?
A practice may add these controls through an approved clinical system or integration. Compare the complete workflow and its safeguards with the specific CDSS alternative; do not assume either product category supplies them automatically.
What does clinical validation mean for a CDSS?
Clinical validation evaluates whether a system performs appropriately for its intended clinical use and patient population. Independent, peer-reviewed evidence can strengthen that assessment, but authorship or publication alone does not establish validity. Ask four questions:
- Accuracy. How often does the system make the right recommendation for this patient population?
- Safety. When it is wrong, does it fail toward harm or toward caution?
- Population specificity. Does it work as well across ages, sexes, comorbidities, and ethnicities?
- Real-world performance. How does it perform when practitioners use it in daily practice?
Ask the vendor for the evidence supporting each of these points, and assess its relevance and limitations.
What has been published about ChatGPT?
ChatGPT is a general-purpose model. Independent researchers have tested it on medical tasks. One example is Kung et al. in PLOS Digital Health (2023), which evaluated it on USMLE questions. Results on exam questions do not by themselves validate a particular model for longevity medicine, peptide prescribing, or a practice's workflow.
A chatbot's answer to a clinical question may often be reasonable. "Often reasonable" is a different standard from "validated for this population."
What should you ask a CDSS vendor about validation?
- "What peer-reviewed studies validate this system?" In our view, a mature product should be able to point to more than one paper in a medical journal, beyond its own white papers.
- "For what patient populations and conditions is it validated?" Check that it includes your patients' ages, comorbidities, and medications.
- "How is the algorithm updated when guidelines change?" Ask what the vendor monitors and how quickly it makes changes.
- "Can I see which version I used for a given decision?" You will need this if a decision is audited.
- "What happens if the system produces a harmful recommendation?" Ask how fast users are notified and how the incident is investigated.
- "What does your audit trail capture, and can I export it?" You need timestamps, user ID, inputs, recommendations, and your decisions, in a format you control.
Can an audit trail help in a malpractice claim?
It can support your account of what you did. It does not decide the claim.
Start with your coverage. Check your malpractice policy for AI language. Ask your carrier in writing whether your policy covers claims involving AI-assisted decisions, and under what conditions.
A plaintiff's attorney will ask about your process. In a deposition, expect "Walk me through how you decided on this dose." If your answer is "I asked ChatGPT," the follow-up questions are what you asked, what it said, and what you did with the answer. An exported chat can show the first two if it still exists. The final decision and reasoning must also be documented; they are not established by the AI response alone.
With a CDSS audit trail, verify that you can produce:
- The date and time you accessed the system
- The patient data you entered
- The recommendation the system generated
- Your documented reasoning
- Whether you approved, modified, or rejected the recommendation
- The algorithm version in use
That record shows that you followed a review process, that the tool had evidence behind it you can point to, and that you made a deliberate decision. It documents the process for a reviewer to assess. It does not guarantee an outcome.
What should you check before choosing a CDSS?
This practical checklist is not exhaustive. Use it to evaluate the governance controls offered by a specific product.
What technical requirements should a CDSS meet?
- Audit trail logging. The system logs user ID, timestamp, input data, the recommendation generated, your decision, and the outcome if available.
- Version control. You can see which algorithm version was running when you made a decision, and the system tells you what changed in each update.
- Practitioner review workflow. The system requires you to review and formally approve recommendations before they are acted on.
- Data sourcing transparency. The vendor explains what data the model was built on and whether it is limited to peer-reviewed sources.
- Security and HIPAA. Data is encrypted in transit and at rest, and the vendor signs a Business Associate Agreement (BAA).
- EHR integration. The system can pull data from and write back to your EHR securely, which reduces manual entry and gaps in the record.
What regulatory and compliance requirements should it meet?
- Clinical validation. Peer-reviewed studies support accuracy and safety, ideally in your patient population.
- FDA guidance alignment. The vendor can explain how its product fits FDA's CDS software guidance, including whether it is device or non-device CDS and how it lets you review the basis for each recommendation.
- State-specific alerts. Ask whether the product alerts you to state regulatory changes. For peptide practitioners, this matters because state boards and attorneys general act on their own timelines.
- Ongoing monitoring. The vendor tracks performance over time and tells you if accuracy drops.
- Incident response. The vendor has a written procedure for a harmful recommendation, including how quickly users are notified.
- Liability and indemnification. Ask whether the vendor carries liability insurance and whether it indemnifies you if the system fails. Get the answer in writing.
What should you ask a CDSS vendor?
- "Can you demo the audit trail?" Watch the vendor generate a recommendation, approve it, and show you the logged record.
- "What clinical evidence supports this for my specialty?" The answer should cite peer-reviewed literature relevant to your patients.
- "If I'm audited or sued, what records can I export?" Ask to see a sample export.
- "How often do you update the algorithm, and how will I know?"
- "Do you sign a Business Associate Agreement?" A vendor handling protected health information on your practice's behalf may be a business associate; confirm the required agreement and safeguards before use.
- "What is your uptime commitment?" Ask for the vendor's uptime SLA in writing.
How would this play out in an investigation or a claim?
Both scenarios below are hypothetical. The CDSS examples assume the practice has verified that its system captures the specified records; these capabilities are not guaranteed by the product category.
Scenario 1: a state attorney general investigation
Your state's Attorney General's office opens an investigation into prescribing unapproved peptides. It sends a demand letter asking for all records of your clinical decision-making for peptide prescriptions over a stated period.
If you used a general chatbot, an available export may show the conversation. In this hypothetical, assume the practice did not connect it to the patient record or document the clinician's decision and reasoning. Those are documentation gaps; an export alone does not fill them. The office may ask for more, and your state board may open its own inquiry.
If you used a CDSS with audit trails, you produce the log of your peptide-related decisions for the period. Each entry shows the patient data, the recommendation, your documented reasoning, and your decision. You can also show your governance process, such as quarterly outcome reviews and override notes. You answer the request with records. That doesn't decide how the investigation ends, but it puts your process on paper.
Scenario 2: a malpractice claim
A patient has an adverse effect after a peptide dose you prescribed and sues for negligence, claiming you did not follow the standard of care.
If you used a general chatbot without separately documenting the patient linkage and your final reasoning, the deposition may go like this:
- Attorney: "How did you decide on that dose?"
- You: "I used AI to help think it through."
- Attorney: "Show me the conversation."
- You: "Here is the exported chat."
- Attorney: "Where does it show which patient this was for, and what you decided after reading it?"
- You: "It doesn't."
The attorney can argue that you have no record of your own reasoning.
If you used a CDSS with audit trails:
- Attorney: "How did you decide on that dose?"
- You: "Here is the audit trail showing the recommendation, my reasoning, and my decision."
- Attorney: "What evidence is behind the system?"
- You: "Here are the published studies and the validation summary the vendor provides."
If the case goes to trial, you have documentary evidence of how you reached the decision.
Frequently asked questions
Can I use ChatGPT for clinical decision support?
OpenAI's usage policies require appropriate licensed-professional involvement for tailored medical advice. Evaluate the specific product, intended use, evidence, privacy safeguards, and clinical workflow. Retained chats may be exportable in eligible accounts, but the practice must verify how patient linkage, clinician review, final decisions, and reasoning are recorded. Apply the same checks to a CDSS.
Doesn't a CDSS cost more than ChatGPT?
Get written pricing from each vendor and compare the features, implementation work, and ongoing staff time required. Do not assume either product category is always cheaper.
What should my audit trail include at minimum?
Who (user ID), what (the exact recommendation), when (timestamp), and the decision (approved, modified, or rejected). Your documented reasoning is the next most useful field. Some systems also capture outcome data.
How often should I review my audit trails?
We suggest quarterly. Pull a sample of decisions and look for patterns:
- Are the recommendations reasonable?
- Are you overriding the system often, and why?
- Have patient outcomes matched the recommendations?
- Were there adverse events?
Document each review.
Can I use more than one CDSS platform?
Yes. Keep one governance process that covers all of them, record which platform you used for which decision, and train your team on each.
What if my CDSS is breached or goes offline?
Ask before you sign. Your contract should cover the vendor's uptime SLA in writing, breach notification procedures, preservation of the audit trail during an incident, and a disaster recovery plan.
How can you see audit trails in practice?
Book a demo and ask how Scriptura's clinical decision support captures recommendations, clinician decisions, and reasoning. Confirm current access and onboarding requirements with the team.
About the author
Educational and regulatory information only
This article is for educational and regulatory information only. It is not legal or medical advice and does not create an attorney-client or clinician-patient relationship. Confirm current requirements with your state boards, your malpractice carrier, and a healthcare attorney licensed in your state before acting.
